Galapagos NV
GLPG
#4563
Rank
โ‚น189.74 B
Marketcap
โ‚น2,838
Share price
-0.57%
Change (1 day)
24.35%
Change (1 year)

Galapagos NV (GLPG) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚น0.79 Billion

According to Galapagos NV's latest financial reports the company's total debt is โ‚น0.79 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Galapagos NV - Total debt on balance sheet (from 2008 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚น1.04 B18.49%
2023-12-31โ‚น0.88 B-54.57%
2022-12-31โ‚น1.94 B-14.14%
2021-12-31โ‚น2.26 B-14.5%
2020-12-31โ‚น2.64 B30.58%
2019-12-31โ‚น2.02 B
2018-12-31N/A-100%
2017-12-31โ‚น0.68 M-84.69%
2016-12-31โ‚น4.5 M-46.11%
2015-12-31โ‚น8.35 M-35.09%
2014-12-31โ‚น12.87 M-61.61%
2013-12-31โ‚น33.53 M14.31%
2012-12-31โ‚น29.33 M-51.26%
2011-12-31โ‚น60.17 M-18.9%
2010-12-31โ‚น74.2 M-24.78%
2009-12-31โ‚น98.65 M-12.92%
2008-12-31โ‚น0.11 B-54.74%
2007-12-31โ‚น0.25 B-44.86%
2006-12-31โ‚น0.45 B6.88%
2005-12-31โ‚น0.42 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
AstraZeneca
AZN
โ‚น2.931 T 370,540.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚น4.114 T 520,047.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น2.293 T 289,889.02%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
โ‚น6.175 T 780,695.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
โ‚น6.21 B 686.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น1.162 T 146,886.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น1.533 T 193,818.15%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚น2.143 T 270,928.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น3.716 T 469,833.20%๐Ÿ‡บ๐Ÿ‡ธ USA